Chris Hogg

Chris Hogg has a diverse work experience spanning over two decades. Chris is currently the Co-founder and CEO of Marley Medical, a position they have held since August 2021.

Prior to this, Chris held various leadership roles at Propeller Health. From January 2018 to June 2020, they served as the Chief Commercial Officer, and from July 2014 to January 2018, they were the Chief Operating Officer.

Before joining Propeller Health, Chris worked at Practice Fusion as the Head of Data Science & Data Products from February 2013 to August 2014. Chris'srole involved creating a big data group to analyze electronic health records (EHR) data and developing data-driven products for consumers and doctors.

In 2011, Chris co-founded and served as the CEO of 100Plus, a mobile health start-up that utilized data analytics and location-based technology to engage users with their health.

Additionally, Chris gained experience in the pharmaceutical industry, working as the Cardiovascular Area Lead - Commercial Strategy at Gilead Sciences from March 2009 to October 2011. Chris also held roles in strategic market planning and analytics at CV Therapeutics, Inc. from 2006 to 2009, and as an Associate Director in healthcare at UBS Investment Bank from 2003 to 2006.

Chris started their career as a Molecular Biology Research Associate at Strata Biosciences from 1998 to 2001. Overall, their work experience showcases a strong background in healthcare, data analysis, and leadership roles.

Chris Hogg has a Bachelor's degree in Biology from Brown University, which they obtained between 1993 and 1997. Chris later pursued an MBA with Honors in Strategy, Entrepreneurship, and Finance from The University of Chicago Booth School of Business, completing it from 2001 to 2003.